AgingNCT06638060
Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Older Adults Department PHC
An observational study of Aging, run by Medtronic - MITG at 1 site in Canada.
Trial summary
To confirm feasibility and accessibility of the CCPC Platform (Oxymotion, Bridge Health Solutions medication adherence software, CloudDX home kit) in two different environments - 1) hospital (Acute Care for Elderly Unit) and 2) at-home . Read more about this study
- Who is it for?
- Ages 65 years and olderHealthy volunteers can take part
- Conditions the study is for
- Aging
- How many people
- 15 participants
- Where
- 1 siteCanada
- Study dates
- 13 Mar 2025to 21 Jun 2028
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- Healthy volunteers accepted
- Older adult
Study population: The Acute Care for Elderly Unit at SPH for 40 inpatients over the age of 65.
Who may be able to join
- Inpatients on the Acute care of the Elderly ward.
Who cannot join
- Lack of capacity to consent to the study including moderate-severe dementia or delirium
- Unable to use (or does not have a caregiver who can help put on) study monitoring device at home
- Unable to complete (or does not have a caregiver who can help complete) study questionnaires by electronic (mobile, tablet, or computer), paper, nor phone
- Patient with known allergic reactions to any part material of the device
- People under 40kg
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Canada1 site, 1 recruiting
- Recruiting
St. Paul'sHospital
Vancouver, British Columbia, V6Z 1Y6
Janet Kow, MD, jkow@providencehealth.bc.ca
Janet Kow, MD
About this study
To confirm feasibility and accessibility of the CCPC Platform (Oxymotion, Bridge Health Solutions medication adherence software, CloudDX home kit) in two different environments - 1) hospital (Acute Care for Elderly Unit) and 2) at-home .
- Conditions
- Aging
What is being measured
The primary outcome is the main question the study is designed to answer.
Collect patient and clinicians' feedback about the CCPC Platform
This will be completed via an assessment of the quantitative data on how long and how often patients use this monitoring and what were the reasons that patients took the monitors on and off.
Measured: From enrollment to the end of follow up at 10 days
Collect patient and clinicians' feedback about the CCPC Platform
This will be completed via an assessment of the Usability Questionnaire.
Measured: From enrollment to the end of follow up at 10 days
Collect patient and clinicians' feedback about the CCPC Platform
This will be completed by an evaluation for potential harm, e.g. anxiety questionnaire and any patient-reported adverse events.
Measured: From enrollment to the end of follow up at 10 days
Confirm the technical goals of the CCPC platform are met.
This will be completed by ensuring clinician workflow is met, via feedback sessions (e.g. conversations, questionnaires).
Measured: From enrollment to the end of follow up at 10 days
Confirm the technical goals of the CCPC platform are met.
This will be completed via an assessment of the data flow: does the correct patient data reach the clinicians at the right time?
Measured: From enrollment to the end of follow up at 10 days
Confirm the technical goals of the CCPC platform are met.
This will be completed by determining if the CCPC platform provided a holistic view of each patient with vitals, medication, labs and other collected data.
Measured: From enrollment to the end of follow up at 10 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Oct 2024
- Study start13 Mar 2025
- Primary completion21 Jun 2027 (estimated)
- Study completion21 Jun 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AgingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 15 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Medtronic - MITG
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Excelar, Cloud DX Inc., Bridge Health Solutions, Providence Healthcare
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06638060
- Sponsor's protocol ID
- H24-00744
- Status last verified
- Oct 2026
- First submitted
- 16 Sep 2024
- Last updated
- 15 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No